Are you a biopharmaceutical company eager to launch your first EU-approved drug in France? Don't let the complex and lengthy process of establishing a compliant subsidiary slow you down.

Discover key insights on:

• How a pharmaceutical company cut 18 months off the standard timeline for establishing its authorized local subsidiary in France. ​
• The primary and secondary goals of rapidly setting up a compliant subsidiary and accessing local expertise without unnecessary recruitment. ​
• The challenges of obtaining the "Exploitant" license and navigating the complex regulatory landscape in France. ​
• The step-by-step process required to establish a subsidiary, including recruiting a Responsible Pharmacist, filing the dossier to ANSM, and more. ​
• The successful outcome of entering the French market efficiently while maintaining regulatory compliance. ​